Ibio Inc IBIO

Healthcare Biotechnology

iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. Its pre-clinical pipeline of immuno-oncology targets the treatment of solid tumors, glioblastoma, head, and neck cancers. Its pipeline includes IBIO-101, TROP-2 x CD3, MUC16, EGFRvIII, CCR8, and Target 5. IBIO-101 is an anti-CD25 monoclonal antibody (mAb) that has demonstrated in preclinical models of disease the ability to bind and deplete immunosuppressive regulatory T (Treg) cells to inhibit the growth of solid tumors.

NYSEAM:IBIO - Post by User

Ibio Inc > If Your Wondering Why...

<< Previous

Bullboard Posts

Next >>

Comment by GajjarDron Jun 17, 2022 3:33pm

81 Views

Post# 34765523

RE:If Your Wondering Why...

This is pretty interesting. Why would not FDA approve the pure form I wonder now?

Unimaginatively wrote:
there hasn't been much KanCer cures released... its because is a vitamin b17 deficiency... can get it in apricot kernels. Health Canada says to eat no more than 3 per day. Check out Edward Griffin's book A World Without Cancer or YouTube the video.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec